Arthritis & Rheumatism

New oral treatment option for rheumatoid arthritis

Patients suffering from rheumatoid arthritis are treated for around six months with the standard anti-rheumatic agent methotrexate, to which many patients respond very well. However, if they do not respond and no remission ...

Arthritis & Rheumatism

Study reveals enormous advances for rheumatoid arthritis patients

People living with Rheumatoid Arthritis have experienced significant improvements in their daily lives which is probably down to early and more aggressive treatment of the disease, according to new research from The Universities ...

Arthritis & Rheumatism

New research reveals impact of rheumatoid arthritis in the workplace

The National Rheumatoid Arthritis Society has announced findings from a study conducted in partnership with The University of Manchester that investigates the impact of rheumatoid arthritis and adult juvenile idiopathic arthritis ...

Arthritis & Rheumatism

Study links intestinal bacteria to rheumatoid arthritis

Researchers have linked a species of intestinal bacteria known as Prevotella copri to the onset of rheumatoid arthritis, the first demonstration in humans that the chronic inflammatory joint disease may be mediated in part ...

Arthritis & Rheumatism

Vigilance for kidney problems key for rheumatoid arthritis patients

Rheumatoid arthritis patients are likelier than the average person to develop chronic kidney disease, and more severe inflammation in the first year of rheumatoid arthritis, corticosteroid use, high blood pressure and obesity ...

Arthritis & Rheumatism

Gut bacteria can cause, predict and prevent rheumatoid arthritis

The bacteria in your gut do more than break down your food. They also can predict susceptibility to rheumatoid arthritis, suggests Veena Taneja, Ph.D., an immunologist at Mayo Clinic's Center for Individualized Medicine. ...

Arthritis & Rheumatism

Immunotherapy reduces cardiovascular risk in rheumatoid arthritis

Immunotherapy reduces cardiovascular risk in patients with rheumatoid arthritis, according to research presented today at Frontiers in CardioVascular Biology (FCVB) 2016 by Professor Aida Babaeva, head of the Department of ...

page 6 from 23